HMP Global September 8, 2024

Ahead of his session at the 2024 Cape Cod Symposium on Addictive Disorders, “CDC Opioid Guideline Update: What EVERYONE Needs to Know,” the Psychiatry and Behavioral Health Learning Network asked Mark Garofoli, PharmD, MBA, clinical assistant professor and director of experiential learning for the West Virginia University school of pharmacy, a few questions about what these guideline changes mean for addiction treatment.

Dr Garofoli discusses the key changes in the CDC’s 2022 Opioid Guideline Update and their impact on clinical practice, highlights the expanded scope of the guidelines to all outpatient settings, the nuanced approach to pain management, and the importance of patient-provider communication when considering opioid therapy.

For more coverage on the 2024 Cape Cod Symposium on Addictive...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Interview / Q&A, Pharma, Pharma / Biotech, Provider, Trends
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Trump tariffs could drive up generic drug costs: 5 takeaways
Bridging the Gap: Pharmacists' Role in Advancing Pharmacogenomic Testing Standards
The Evolving Role of Pharmacists in Custom Pathway Implementation
Pharma Pulse 11/25/24: Deepening Patient Relationships,

Share This Article